Neal Bhatia, MD, weighs the newly approved Ameluz PDT regimen for sBCC against Mohs surgery, citing its 66% composite response rate.
News|Articles|August 3, 2026
3 Gastroenterology Headlines You Missed in July 2026
Author(s)Alex Hillenbrand
Fact checked by: Chelsie Monroe, APN
Gastroenterology in July 2026: FDA approves Freenome's SimpleScreen CRC blood test, plus new duvakitug data in UC and Crohn disease.
Advertisement
Advertisement
July brought a milestone US Food and Drug Administration (FDA) approval in colorectal cancer (CRC) screening and fresh phase 2b data in inflammatory bowel disease (IBD), both with real implications for gastroenterology and primary care practice.
Related to this article
Read 6 late-breaking updates from ERS Congress 2026 that clinicians managing respiratory disease should know.
The resubmission follows an FDA Complete Response Letter and cites human factors data showing pouch-opening time fell from 17 to 3 seconds.
The approval, backed by FINE-ONE data showing a 28% UACR reduction at 6 months, is the first new CKD treatment for this group in 3 decades.
In this Q&A, Armand explains why eczema visits spike during wildfire smoke events and how allergic patients can protect themselves.
In this Q&A, Leon Kircik, MD, discusses challenging watch-and-wait for molluscum contagiosum with berdazimer gel, 10.3%, at LEADderm 2026.
New ASH guidelines recommend higher ferritin thresholds to improve the diagnosis of iron deficiency across key populations.
In this Q&A, Alysse Wurcel, MD, translates qualitative barriers into 8 concrete tactics healthcare practices can use to expand penicillin allergy delabeling.
Advertisement
Advertisement